Thiamine Market is slated to Witness Tremendous Revenue Growth of US$ 715.32 Mn by 2032 | Future Market Insights, Inc.

Changing Lifestyle and Increased Demand for Health Supplements Catalyze the Thiamine Market: In 2021, Asia Pacific had a revenue share of approximately 35.0%, dominating the market. This is explained by the increase in consumer demand for goods from industries including food, drink, and dietary supplements

NEWARK, Del, Aug. 02, 2022 (GLOBE NEWSWIRE) -- The thiamine market is expected to see a significant CAGR of 13.9%, and is projected to increase from US$ 170.9 million in 2021 to US$ 715.32 million by 2032.

Thiamine's expanding use in mental health is driving up the market size, as its uses go beyond only physical health. Additionally, the market leaders for thiamine, like Jiangsu Jubang Pharmaceutical Co. Ltd, work hard to preserve their leadership positions by bringing in the biggest percentage of revenue and snatching up the largest portion of the market.

The product's expanding function in energy metabolism, as well as the growth and development of healthy cells, is what largely drives the thiamine market. The growing demand for thiamine is mostly due to increased public awareness of the human body's thiamine deficiency.

Sales of thiamine are expanding, as it is used by both humans and animals. Animals are given the chemical to protect their livers and kidneys against lead-induced lipid peroxidation. It is essential for both the development and growth of healthy cells, as well as for human energy metabolism.

To Get Sample Copy of Report visit @

The increased frequency of illnesses and the lack of knowledge and awareness surrounding thiamine deficiency may be limiting factors for the growth of the thiamine market. Furthermore, this shortage can lead to a number of other serious health issues.

Due to the country's rising healthcare spending, aging population, improved medical facilities, changing pharmacy distribution networks, and cutting-edge technologies, the United States is one of the main consumers of protein components.
Key Takeaways of the Thiamine Market

  • The thiamine market is expected to have a CAGR of 13.9% during the forecast period.
  • The thiamine market is anticipated to have a valuation of US$ 715.32 million by 2032.
  • The thiamine market had a valuation of US$ 170.9 million in 2021.
  • The thiamine market is segmented based on surgical application, wherein the dietary supplementary segment had a CAGR of 30.1% in 2021.
  • The pharmaceutical segment holds the second leading position as a result of the usage of thiamine in treatments for a number of disorders.
  • The Asia Pacific dominated thiamine market, with a CAGR of 35.0% in 2021.
  • The North America thiamine market is expected to expand rapidly, with a prodigious share during the forecast period.

Ask Our Analyst More about Report @

Competitive landscape: Fresh Companies Are Meeting The Product Demand

Due to the increasing customer demand for the products and the dwindling supply of manufacturers, there are many opportunities for the existing firms to gain a strategic and competitive advantage. With the assistance of experienced and productive R&D, new businesses can create goods that are ready for the market.
In order to gain a competitive edge and ensure consumer satisfaction, the top players in the thiamine market have taken a number of strategic actions, including setting up various research programs, lowering prices, and carrying out profit-making and expansion initiatives.

Recent Developments: Innovations and Product launches

  • The US Food & Drug Administration (USFDA) has given final permission for Aurobindo Pharma Limited to produce and sell Thiamine HCl Injection 200 mg/ 2 mL Multi-Dose Vials.
  • February 18, 2021 - Through its US subsidiary, Hikma Pharmaceuticals USA Inc. The multinational pharmaceutical business Hikma Pharmaceuticals PLC (Hikma) has introduced Thiamine Hydrochloride Injection, USP, 200mg/2mL, in the US.

Key segments
By Application:

  • Food & Beverages
  • Animal Feed
  • Pharmaceuticals
  • Dietary Supplements

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

Request Complete TOC Of this Report @   

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

Sialendoscopes Market Growth: The Sialendoscopes market is expected to improve with a CAGR of 5.6% during 2022-2032.

Tibial Neuromodulation Devices Market Size: The sales of tibial neuromodulation devices are projected to rise at a CAGR of 8.1% during the forecast period 2022-2032.

Veterinary Injectable Devices Market Share: The veterinary injectable devices market is poised to witness a CAGR of 2.3% during the years 2022 to 2032.

Scoliosis Management Market Forecast: The scoliosis management market is likely to record a CAGR of 3.9% during the forecast period, up from US$ 2,942.8 Mn in 2022 to reach a valuation of US$ 4,489.0 Mn by 2032.

Knotless Tissue Control Devices Market Trends: global knotless tissue control devices market is projected to secure a market value worth US$ 672.6 Million by 2032

Reverse Transcriptase Enzymes Market Volume: The reverse transcriptase enzymes market is likely to reach US$ 481.8 Million with a CAGR of 3.4% by 2032.

Large Volume Wearable Injectors Market Analysis: Large Volume Wearable Injectors’ demand is anticipated to be valued at US$ 2,800.0 Million in 2022, forecast to grow at a CAGR of 8.9% to be valued at US$ 7,142.3 Million from 2022 to 2032.
Quantitative Pathology Imaging Market Outlook: The global quantitative pathology imaging market is forecasted to be appraised at US$ 9.5 Billion by 2032.

Revision Knee Replacement Market Forecast: The revision knee replacement market is estimated to reach US$ 2 Billion with a CAGR of 4.1% by 2032.

About Us   

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.  


Future Market Insights Inc.  
Christiana Corporate, 200 Continental Drive, 
Suite 401, Newark, Delaware - 19713, USA   
T: +1-845-579-5705   
For Sales Enquiries:    
Browse Other Reports:  
LinkedIn| Twitter| Blogs